On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should simply pass legislation to allow the government to set the price for prescription medications. That approach, whether wise on policy grounds or not, at least has the virtue of fidelity to our constitutional
Walter G. Copan Opinion: Removing patent rights to lower drug costs is dangerous precedent The Denver Post
Paul R. Michel U.S. patent system weakens: Protect IP to keep American tech at the top VentureBeat
Paul R. Michel https://www.washingtontimes.com/news/2022/mar/16/chinas-formidable-technology-challenge/ The International Business Times
Adam Mossoff The U.S. must fix its innovation engine: the patent system STAT
Paul R. Michel https://www.ibtimes.com/us-economy-2022-diversity-inclusion-heartland-3425396 The International Business Times
Andrei Iancu, David Kappos, and Paul R. Michel https://fortune.com/2022/03/04/new-covid-pills-patents-pfizer-merk-ip-pandemic-pharma-health-iancu-kappos-michel/ Fortune
Paul R. Michel https://news.trust.org/item/20220218102516-a1p08 Reuters
Adam Mossoff Thank You, Senator Tillis, for Recognizing the Need for Evidence-Based Policymaking in Patent Law IPWatchdog
Paul R. Michel The Supreme Court is partly to blame for the Covid-19 test kit shortage STAT (Also published by the Boston Globe)
Barney Cassidy https://www.realclearpolicy.com/articles/2022/01/06/can_we_please_get_serious_about_patents_and_drug_pricing_810732.html RealClearPolicy
